Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1436947 | 1.00 | HTR6 (0.51) | HTR6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL4313805 | 0.85 | HRH1 (0.44) | HTR6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL30733631 | 0.83 | HTR6 (0.54) | HTR6 | |
| SCHEMBL21274261 | 0.83 | HTR6 (0.54) | HTR6 | |
| SCHEMBL11625344 | 0.83 | HRH1 (0.49) | HTR6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7618202 | 0.80 | HTR6 (0.67) | HTR6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL2231213 | 0.78 | CHRM2 (0.40) | HTR6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL6130448 | 0.73 | HTR6 (0.74) | HTR6L3MBTL1ALDH1A1MEN1KMT2A | |
| SCHEMBL6919946 | 0.72 | HTR6 (0.58) | HTR6HRH1 | |
| SCHEMBL31121639 | 0.72 | HTR6 (0.56) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11440979-B2 | Catalysts, catalyst systems, and methods for using the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11440979-B2 | Catalysts, catalyst systems, and methods for using the same | CYCS, CAT, PARG | HTR6 3973/4885CHRM2 4376/4885CHRM4 3845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.